Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial).

Elizabeth E RougheadNicole L PrattGaynor ParfittDebra RowettLisa M Kalisch-EllettLuke BereznickiTracy MerlinMegan CorlisAi Choo KangJoseph WhitehouseRebecca BiltonCamille SchubertStacey TorodeThu-Lan KellyAndre Q Andrade Dannielle PostGereltuya DorjJustin CousinsMackenzie WilliamsRenly Lim

Published in: Age and ageing (2022)

The use of validated tools by pharmacists to detect signs of medicine-induced deterioration is a model of practice that requires further research, with promising results from this trial, particularly with regards to improved cognition.

Keyphrases

study protocol
healthcare
high glucose
clinical trial
diabetic rats
randomized controlled trial
phase iii
phase ii
mental health
primary care
drug induced
endothelial cells
oxidative stress
open label
mild cognitive impairment
multiple sclerosis
cross sectional
electronic health record